Guardant Health Inc [GH] stock is trading at $42.89, up 5.54%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 9.08% over the last week, with a monthly amount drifted -5.49%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on January 23, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $60. Previously, Guggenheim upgraded its rating to Buy on June 28, 2024, and kept the price target unchanged to $36. Guggenheim initiated its recommendation with a Neutral. In a note dated November 13, 2023, Raymond James upgraded an Outperform rating on this stock but restated the target price of $27.
Guardant Health Inc [GH] stock has fluctuated between $15.81 and $50.89 over the past year. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $42.89 at the most recent close of the market. An investor can expect a potential return of 21.24% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 739.02M for the trailing twelve months, which represents a growth of 30.16%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.6%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is 13.12 and Total Capital is -0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.57 points at the first support level, and at 40.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.65, and for the 2nd resistance point, it is at 44.41.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 4.68. Further, the Quick Ratio stands at 4.36, while the Cash Ratio is 2.33. Considering the valuation of this stock, the price to sales ratio is 7.16.
Transactions by insiders
Recent insider trading involved Joyce Meghan V., Director, that happened on Mar 03 ’25 when 100.0 shares were sold. Director, Joyce Meghan V. completed a deal on Mar 03 ’25 to buy 100.0 shares. Meanwhile, Director Tariq Musa sold 116.0 shares on Feb 20 ’25.
